Generated by GPT-5-mini| Regulation (EC) No 1907/2006 | |
|---|---|
![]() User:Verdy p, User:-xfi-, User:Paddu, User:Nightstallion, User:Funakoshi, User:J · Public domain · source | |
| Name | Regulation (EC) No 1907/2006 |
| Type | Regulation |
| Issued by | European Commission |
| Adopted | 18 December 2006 |
| Effective | 1 June 2007 |
| Amends | Council Regulation (EEC) No 793/93; Directive 91/414/EEC |
| Status | In force |
Regulation (EC) No 1907/2006 is a European Union legal instrument establishing a comprehensive regime for chemicals aimed at protecting human health and the environment while enhancing competitiveness and innovation in industry. It created an integrated framework requiring information generation, data sharing, risk management and controls over hazardous substances across manufacturing and supply chains. The Regulation interacts with other legal instruments and institutions across the European Union, shaping chemical policy and industrial practice in Germany, France, United Kingdom, Italy and other Member States.
The Regulation was developed in the context of EU policymaking influenced by outcomes from United Nations Environment Programme, deliberations at the Organisation for Economic Co-operation and Development and jurisprudence from the European Court of Justice. It responded to public concern after high-profile incidents and debates involving Silent Spring-era controversies, regulatory reforms such as Directive 67/548/EEC, and policy initiatives led by the European Chemicals Agency and the European Parliament. The purpose was to replace and consolidate earlier instruments like Directive 91/414/EEC and to implement the precautionary approaches endorsed at the Rio Earth Summit and in Stockholm Convention negotiations.
The text set out obligations for substance notification, information exchange, and risk assessment, defining criteria for substances of very high concern comparable to provisions in instruments such as the Montreal Protocol and the Rotterdam Convention. It established processes for dossiers, technical summaries and chemical safety reports that reference standards applied by bodies like the European Food Safety Authority and practices seen in United States Environmental Protection Agency assessments. Provisions covered mixtures, intermediates and articles, and created thresholds and deadlines that affected sectors including BASF, Bayer, Dow Chemical Company, DuPont and Royal Dutch Shell supply chains.
The Regulation interfaces with the CLP Regulation adopted pursuant to the United Nations Globally Harmonized System of Classification and Labelling of Chemicals and aligns labelling requirements with international obligations under the World Health Organization. It established coordination mechanisms with national authorities such as Agence nationale de sécurité sanitaire de l'alimentation, de l'environnement et du travail in France and Bundesinstitut für Risikobewertung in Germany to ensure consistent hazard communication. The interplay affected industrial actors including Ineos, AkzoNobel, Johnson & Johnson, and regulatory science groups linked to European Chemicals Agency committees.
The Regulation created the REACH architecture, setting out registration deadlines, evaluation processes, and an authorisation regime inspired by frameworks in California Air Resources Board policy and techniques used by the International Agency for Research on Cancer. It established a role for the European Chemicals Agency in Helsinki to manage dossiers, dossier evaluation, substance evaluation and restriction proposals, and to operate expert committees akin to those in European Medicines Agency governance. Companies such as GlaxoSmithKline and AstraZeneca were affected in their research and supply practices by obligations to register substances and seek authorisation for bisphenol A-like or phthalates-class chemicals.
Manufacturers, importers and downstream users, including multinational corporations like Unilever and trade associations such as Chemical Industry Council-style bodies, bear primary responsibilities for data generation and safety assessments. Member State competent authorities and agencies including the European Commission and the European Chemicals Agency share enforcement and decision-making roles; non-governmental organisations such as Greenpeace and Friends of the Earth participate in advocacy and transparency campaigns. Market surveillance bodies in Sweden, Netherlands, Poland and other Member States implement controls alongside customs authorities and courts adjudicating disputes influenced by precedents from the European Court of Justice.
Implementation involved phased registration deadlines, data-sharing consortia and compliance checks, with enforcement actions undertaken by national authorities and referrals to the European Court of Justice for infringements. Industry transnational responses included formation of consortia and reliance on third-party service providers in Helsinki and Brussels for dossier preparation. Compliance mechanisms echo enforcement regimes in instruments like the REACH-IT system and administrative procedures similar to those used by the European Medicines Agency and World Trade Organization dispute settlement in cross-border matters.
The Regulation had substantial impacts on product stewardship, research prioritisation and supply-chain transparency, influencing firms such as Siemens, Philips, Samsung and sectors including automotive suppliers tied to Volkswagen and Renault. Critics, including business federations and some Member State ministries, argued about administrative costs, data protection and innovation effects, invoking debates resembling those around the General Data Protection Regulation and WTO compliance. Environmental and public-health advocates highlighted successes in restricting hazardous substances while urging stronger measures akin to international treaties such as the Rotterdam Convention and Stockholm Convention.